drugset / Trial / NCT02444936
ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors
RandomizedParallel-groupSingle-blindBasic science
Summary
This study evaluates if the shingles vaccine works in those persons that receive it before they receive chemotherapy for solid organ tumors. Half of the participants will receive the ZOSTAVAX shingle vaccine and half of the participants will not received anything.
Timeline
- Start
- 2015-05-01
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Varivax | Vaccine | 0.65 ml | Subcutaneous |